Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Savio

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oncology Letters|July 12, 2017
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumorsEkaterina Olkhov-Mitsel, Farshid Siadat, Ken Kron, et al.
Urologic Oncology|September 28, 2019
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patientsRenu Jeyapala, Shivani Kamdar, Ekaterina Olkhov-Mitsel, et al.
The Journal of Molecular Diagnostics : JMD|October 13, 2019
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer PatientsAndrea J Savio, Shivani Kamdar, Renu Jeyapala, et al.
European Urology Oncology|June 16, 2019
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform ArchitectureRenu Jeyapala, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
BMC Cancer|February 18, 2016
Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patientsAndrea J Savio, Darshana Daftary, Elizabeth Dicks, et al.
Translational Oncology|February 8, 2017
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerEkaterina Olkhov-Mitsel, Andrea J Savio, Ken J Kron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2019
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in IndiaA Patel, H Kaur, I Xess, et al.
The Journal of Hospital Infection|February 6, 2022
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre studyM Biswal, P Gupta, R Kanaujia, et al.
Urologic Oncology|February 22, 2020
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer gradeThomas Hermanns, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oncology Letters|July 12, 2017
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumorsEkaterina Olkhov-Mitsel, Farshid Siadat, Ken Kron, et al.
Urologic Oncology|September 28, 2019
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patientsRenu Jeyapala, Shivani Kamdar, Ekaterina Olkhov-Mitsel, et al.
The Journal of Molecular Diagnostics : JMD|October 13, 2019
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer PatientsAndrea J Savio, Shivani Kamdar, Renu Jeyapala, et al.
European Urology Oncology|June 16, 2019
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform ArchitectureRenu Jeyapala, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
BMC Cancer|February 18, 2016
Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patientsAndrea J Savio, Darshana Daftary, Elizabeth Dicks, et al.
Translational Oncology|February 8, 2017
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerEkaterina Olkhov-Mitsel, Andrea J Savio, Ken J Kron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2019
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in IndiaA Patel, H Kaur, I Xess, et al.
The Journal of Hospital Infection|February 6, 2022
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre studyM Biswal, P Gupta, R Kanaujia, et al.
Urologic Oncology|February 22, 2020
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer gradeThomas Hermanns, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
Pageof 2